ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.
It is the policy of ASE to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All speakers at the 36th Annual Scientific Sessions have agreed to the following:
• Present recommendations for patient care that are based on current science, evidence, and clinical reasoning, while giving a fair and balanced view of diagnostic and therapeutic options.
• Refer, report, or use in accredited education scientific research in support or justification of a patient care recommendation that conforms to the generally accepted standards of experimental design, data collection, analysis, and interpretation.
• Not present content that advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
• Not to accept any payment or reimbursement for their content from any commercial interests.
• Provide content material that is balanced information on all available options for pharmaceutical identification, trade name of drugs and devices to avoid the appearance of commercial bias.
• Disclose to the program audience when products/services are not labeled for the use under discussion or when the products are still under investigation.
• Comply with patient confidentiality requirements as outlined in the Health Insurance Portability and Accountability Act (HIPAA), by removing all patient and hospital identifiers from all content materials, including presentation slides and handouts.
While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME requires that all financial relationships with ineligible companies be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. Disclosure information is referenced below.
ACCME defines an ineligible company as an entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For specific examples of ineligible companies visit accme.org/standards. ACCME does not consider providers of clinical services directly to patients to be a commercial interest.
RELATIONSHIP CODES
1. SPEAKER/SPEAKERS’ BUREAU
2. CONSULTANT, ADVISOR
3. STOCKHOLDER (NOT INCLUDING DIVERSIFIED MUTUAL FUNDS)
4. RESEARCH FUNDING/SUPPORT (INCLUDES PRINCIPAL OR NAMED INVESTI¬GATOR EVEN IF MANAGED BY INSTITUTION)
5. COMPANY RELATIONSHIP (OWNER, EMPLOYEE)
6. ROYALTIES/PATENT BENEFICIARY
7. OTHER (EDUCATOR OR HONORARIA)
Abraham T.— BMS, Cytokinetics, Tenaya Therapeutics (4)
Acevedo J.— Philips, Bracco (2)
Aday A.— Aeglea, OptumCare, CRC Oncology (2)
Ajmone Marsan N.— GE Healthcare, Philips Ultrasound, Abbott Vascular, Pfizer (1)
Appadurai V.— Abbott Laboratories (7)
Armour A.— Education for the Sonographic Professional (ESP), Inc. (1)
Belani K.— GE Healthcare (2)
Billick K.— Lantheus Medical Imaging (7); Caption Health (GE) (2)
Blaha M.— Novo Nordisk, Novartis, Bayer (2)
Burkhard Mackensen G.— Philips Healthcare (4)
Chetrit M.— Pfizer, Alnylam(2); BMS, Abbott (7)
Crowley J.— Johnson and Johnson (2)
DiLorenzo M.— GE Healthcare (4)
Elgharably H.— LifeNet Health, Edward’s LifeSciences, Artivion (7)
Estep J.— Abbott, Procyrion Inc., Bioventrix Inc. (2)
Ferencik M.— Siemens, HeartFlow, Elucid (2)
Fox T.— Wolters Kluwer, McGraw Hill Medical (6); Canon (4)
Fuller S.— WL Gore, Edwards Lifesciences (2)
Gage A.— Abiomed (1); Zoll Medical (7)
Garbi M.— Edwards Lifesciences (1)
Garg R.— Siemens (1)
Gargani L.— GE Healthcare, Caption Health, SANOFI (2)
Gillam L.— Medtronic, Egnite, Krinsky Co (for GE Healthcare) (2)
Hahn R.— Abbott Vascular, Boston Scientific, Edwards Lifescience, Medtronic, Philips Healthcare (1)
Hill G.— Ultragenyx (2)
Hodges K.— Intuitive Surgical (2)
Jankowski M.— Agitated Solutions Inc., Caption Health (2); Bristol Myers Squibb (1)
Kelly N.— Boston Scientific, Abbott (1)
Khalique O.— Edwards, Siemens, Philips (2)
Klein A.— Kiniksa, Cardiol therapeutics, Ventyx (4)
Koulogiannis K.— Edwards Lifesciences, Abbott (2); 4C Medical (3)
Kraushaar M.— Epsilon (1); MyoKardia (2)
Levy P.— Abbott Congenital (1)
Loyer C.— EchoVet Veterinary Ultrasound Software (5)
MacNamara J.— Cytokinetics, Bristol Myers Squibb (2)
Meece R.— Philips Healthcare (1); Intershunt Technologies LLC (2)
Mehl B.— Lantheus Medical (2); BMS (1)
Mitchell C.— Elsevier, W. L. Gore & Associates contracted research grants to University of Wisconsin-Madison (7); Acoustic Range Estimates (2)
Miyasaka R.— Abbott (2); Edwards (1)
Nambi V.— Insera therapeutics, Ionis, (7); Abbott (4)
Nesbitt G.— BMS (1)
Nikravan S.— Philips, Inc, Fieldworks (2)
Oh J.— Anumana (6)
Park M.— Lantheus Medical Imaging (1)
Patel A.— GE Healthcare, CircleCVI, Area19, Siemens Healthineers, Neosoft (4)
Pellikka P.— Edwards Lifesciences, Ultromics Ltd, GE Healthcare (4)
Pendyal A.— Solventum (2)
Perry R.— TOMTEC Imaging systems, GE Healthcare, Philips Medical (1)
Petersen S.— Circle Cardiovascular Imaging (2)
Pibarot P.— Edwards Lifesciences, Medtronic, Pi-Cardia (4)
Powell A.— Siemens Medical Solutions USA, Inc, Boston Children’s Hospital and Harvard Medical School (2)
Rassi D.— ASTRAZENECA DO BRASIL LTDA (1)
Robinson J.— Siemens Medical Solutions USA, Inc. (2); Doximitiy, Inc. (3)
Scherer M.— Abbott, Boston Scientific, Edwards Lifesciences (1)
Sengupta P.— RCE Technology, HeartSciences (2)
Shah S.— Abbott, Actelion, AstraZeneca (2)
Strom J.— National Heart, Lung, and Blood Institute, National Institute of Aging, Anumana, Philips Healthcare, EVERSANA Lifesciences, Bracco Diagnostics (4); Bracco Diagnostics, Edwards Lifesciences, Philips Healthcare, General Electric Healthcare, EVERSANA (2)
Tower-Rader A.— Bristol Myers Squibb, Cytokinetics, Edgewise Therapeutics (4)
Wang A.— Bristol Myers Squibb (2); Cytokinetics, Lexicon (4)
Willis J.— General Electric (1)
Xu B.— Bristol Myers Squibb (1)
Yu A.— Avacta Life Sciences (2)
FACULTY WITH NO DISCLOSURES
| Adams D.; Adoe M.; Agarwal V.; Allen J.; Alnaimat S.; Altman C.; Anderson B.; Ansah D.; Anwar Mohammed S.; Aragam J.; Arbic N.; Arora B.; Arya B.; Asch F.; Ashwath M.; Augustine D.; Aurigemma G.; Ayoub C.; Badano L.; Balasubramanian S.; Banerjee A.; Barac A.; Barberato S.; Barker P.; Becky Schwaegler R.; Belcik T.; Berhe L.; Beth Brady M.; Bishop R.; Bonagura J.; Boyle A.; Brabender J.; Bremer M.; Brener M.; Bronshteyn Y.; Brook M.; Brown S.; Burgess P.; Byrd B.; Carlos Plana J.; Carr M.; Cha Y.; Chaszczewski K.; Chen C.; Chen T.; Chiu H.; Chiu J.; Chivington M.; Cho I.; Chou R.; Cohen M.; Collier P.; Collins K.; Cordio M.; Côté E.; Coutinho T.; Crandall I.; Davidson B.; Davis A.; DeCara J.; Delgado V.; Denton M.; DeRose L.; Desai M.; DeWeert K.; Dillenbeck A.; DiMaria M.; Doan T.; Donal E.; Donato Magno J.; Dorfman A.; Doufle G.; Douglas P.; Dove M.; Dudzinski D.; Durham A.; Eduardo Echeverria L.; Edvardsen T.; Eidem B.; El Sabbagh A.; Erickson S.; Fan D.; Farooqi K.; Faza N.; Fields C.; Fleishman C.; Forsha D.; Forshaw T.; France R.; Freed B.; Freud L.; Friedberg M.; Friend L.; Fries R.; Frye C.; Fuller T.; Garcia-Sayan E.; Ghazal M.; Gibson K.; Gleason P.; Grapsa J.; Griffee M.; Grimm R.; Grotenhuis H.; Gruca M.; Hamid N.; Hammond L.; Han Y.; Harrild D.; Hauck A.; Havens C.; Hays A.; Henkin S.; Hill J.; Hodovan J.; Hong G.; Horton K.; Howard-Quijano K.; Hsue W.; Hua L.; Huang T.; Humpheries J.; Humphries J.; Hung J.; Husain N.; Ignatowski D.; Imbrogno M.; Jain A.; Jain R.; Janardhanan R.; Johnson T.; Johnson Madalinski B.; Johri A.; Jone P.; Josowitz R.; Jouni H.; Kadotani S.; Kalvin L.; Kaplinski M.; Keene B.; Kelsey A.; Kim E.; Kim J.; Klassen S.; Knoll P.; Kort S.; Kovalchin J.; Kramer C.; Kramer D.; Krasuski R.; Kruse E.; Kurnides M.; Kutty S.; Kwon Y.; Labovitz A.; Lai W.; Landeck B.; Lang R.; Lanspa M.; Lee D.; Lee H.; Lefebvre B.; LeLeiko R.; Lester S.; Levine B.; Li M.; Liang H.; Linder J.; Lindner J.; Little S.; Liu T.; Liu Y.; Longino A.; Lopez K.; Lopez L.; Lopez M.; Lu J.; Lui G.; Luis Fuentes V.; Lund M.; Maganti K.; Maldonado Y.; Manisty C.; Mankad S.; Marshall J.; Martin R.; Martinez M.; Maskatia S.; Mayer S.; Mayne-Walker T.; McIlwain E.; McNamara P.; Mercer-Rosa L.; Michos E.; Miyabe R.; Monet Strachan G.; Monteagudo A.; Moon-Grady A.; Morris S.; Morrison A.; Mukherjee M.; Mulvagh S.; Muthurangu V.; Nagueh S.; Nanda N.; Narang A.; Narula J.; Narula N.; Negishi K.; Ng J.; Nguyen H.; Nguyen M.; Nicoara A.; Norris M.; Nyman C.; Olivieri L.; Ong G.; Orde S.; Orsinelli D.; Orton C.; O’Sullivan L.; Oxborough D.; Pai Cole S.; Panebianco N.; Paratz E.; Parker M.; Parra D.; Parthiban A.; Partington S.; Patel S.; Pearlman A.; Pechan J.; Pellett A.; Peng L.; Peyvandi S.; Phelan D.; Picard M.; Poh K.; Polsen C.; Popp R.; Potter B.; Pressman G.; Puchalski M.; Qamruddin S.; Quader N.; Rahko P.; Randazzo M.; Rashedi N.; Richards B.; Richardson K.; Rigolin V.; Rios D.; Rivard S.; Rodriguez J.; Roffers A.; Rogers S.; Ronai C.; Rose G.; Rudski L.; Ruggles C.; Ruiz-Bonilla G.; Ryan T.; Sabourin R.; Sachdeva R.; Sadeghpour A.; Safi L.; Salberg L.; Salerno C.; Sanborn D.; Saric M.; Saunders A.; Scalia G.; Schauer A.; Scherrer-Crosbie M.; Schwarzwald C.; Schweitzer M.; Scollan K.; Scze Khoo N.; Sengupta S.; Seo Y.; Shah A.; Shah N.; Shah S.; Shamoun F.; Shea E.; Sheehan J.; Sheu R.; Shook D.; Shrestha N.; Shrivastav R.; Shu X.; Shvilkina T.; Sierra L.; Simona Buta A.; Slesnick T.; Slivnick J.; Snook E.; Sohn J.; Soni-Patel N.; Sorrell V.; Srivastava S.; Stainback R.; Stanley J.; Stepien R.; Stern K.; Stone J.; Sullivan A.; Sutton J.; Tajik J.; Taub C.; Thamman R.; Thavendiranathan P.; Thomas J.; Thompson T.; Thorson K.; Tierney S.; Trahanas J.; Tsaban G.; Tsang W.; Tucay E.; Tworetzky W.; Umland M.; Usuku H.; Vainrib A.; Vaitenas I.; Villemain O.; Visser L.; Vorsanger M.; Walling S.; Wang G.; Warmsbecker J.; Warren M.; Wasfy M.; Wasserman M.; Watanabe T.; Weissman N.; Wells B.; Weng Wong Y.; Wessly P.; West C.; Wiedenfeld N.; Wiegers S.; Wiener D.; Wiley B.; Wilson D.; Wilson H.; Wood M.; Wright A.; Wu K.; Yadava M.; Yamat M.; Yao J.; Yin L.; Yoon Y.; Young L.; Yucel E.; Zee Pin D.; Zern E.; Zhang M.; Zhang Y.; Zhao Q.; Zimmerman K.; Zoghbi W. |